Literature DB >> 18285348

Cannabinoid CB1 receptors are expressed by parietal cells of the human gastric mucosa.

María Ruth Pazos1, Rosa María Tolón, Cristina Benito, Conrado Fernández Rodríguez, Juan José Gorgojo, Manuel Nevado, Mariano Alvarez, Francisco Arias, Francisca Almodóvar, María Teresa Pérez Fernández, José Luis Lledó, Sara González, José Javier Fernández-Ruiz, Julián Romero.   

Abstract

Experimental data suggest that the endogenous cannabinoid system is involved in gastric function in different animal species. In most of them, CB(1) receptors have been localized on vagal terminals innervating the external wall of the stomach. We aimed at studying the putative presence and distribution of these receptors in the human gastric mucosa. To this end, we first performed Western blotting, RT-PCR, in situ hybridization, and immunohistochemical analysis of CB(1) protein distribution in biopsy samples of healthy individuals. To determine the precise cell populations expressing CB(1) receptors, we performed double immunofluorescence plus confocal microscopy analysis of the same samples. Our results show that CB(1) receptors are present in the gastric epithelium of the mucosa. Specifically, they are expressed by a subpopulation of mucosal cells, the acid-secreting parietal cells, as shown by double immunohistochemical staining and by their differential abundance in subregions of the gastric mucosa. These results reinforce the notion of a prominent role for the endocannabinoid system in the gastric function in humans and postulate the use of cannabinoid CB(1) receptors in parietal cells as new therapeutic targets for the regulation of gastric acid production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285348      PMCID: PMC2324193          DOI: 10.1369/jhc.2008.950741

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  17 in total

Review 1.  The gastrointestinal pharmacology of cannabinoids.

Authors:  A A Izzo; N Mascolo; F Capasso
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

Review 2.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus.

Authors:  Angela A Coutts; Andrew J Irving; Ken Mackie; Roger G Pertwee; Sharon Anavi-Goffer
Journal:  J Comp Neurol       Date:  2002-07-08       Impact factor: 3.215

Review 4.  Cell biology of acid secretion by the parietal cell.

Authors:  Xuebiao Yao; John G Forte
Journal:  Annu Rev Physiol       Date:  2002-08-05       Impact factor: 19.318

Review 5.  A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole.

Authors:  Lars Olbe; Enar Carlsson; Per Lindberg
Journal:  Nat Rev Drug Discov       Date:  2003-02       Impact factor: 84.694

6.  Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat.

Authors:  Maristella Adami; Rossitsa Zamfirova; Emil Sotirov; Roman Tashev; Yordanka Dobrinova; Simeon Todorov; Gabriella Coruzzi
Journal:  Brain Res Bull       Date:  2004-12-15       Impact factor: 4.077

7.  The cultured human gastric cells HGT-1 express the principal transporters involved in acid secretion.

Authors:  M Carmosino; G Procino; V Casavola; M Svelto; G Valenti
Journal:  Pflugers Arch       Date:  2000-10       Impact factor: 3.657

8.  Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system.

Authors:  A Kulkarni-Narla; D R Brown
Journal:  Cell Tissue Res       Date:  2000-10       Impact factor: 5.249

9.  Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice.

Authors:  Jeremy P Allen; Alison J Canty; Stefan Schulz; Patrick P A Humphrey; Piers C Emson; Heather M Young
Journal:  J Comp Neurol       Date:  2002-12-16       Impact factor: 3.215

10.  Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

Authors:  Galina Burdyga; Simon Lal; Andrea Varro; Rod Dimaline; David G Thompson; Graham J Dockray
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

View more
  9 in total

1.  Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract.

Authors:  Giorgia Galiazzo; Fiorella Giancola; Agnese Stanzani; Federico Fracassi; Chiara Bernardini; Monica Forni; Marco Pietra; Roberto Chiocchetti
Journal:  Histochem Cell Biol       Date:  2018-06-07       Impact factor: 4.304

2.  Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.

Authors:  Steven G Kinsey; Daniel K Nomura; Scott T O'Neal; Jonathan Z Long; Anu Mahadevan; Benjamin F Cravatt; John R Grider; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2011-06-09       Impact factor: 4.030

3.  MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice.

Authors:  Molly S Crowe; Steven G Kinsey
Journal:  Eur J Pharmacol       Date:  2017-05-03       Impact factor: 4.432

4.  Acute Δ(9)-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice.

Authors:  Steven G Kinsey; Erica C Cole
Journal:  Eur J Pharmacol       Date:  2013-06-11       Impact factor: 4.432

5.  CB1 positive allosteric modulation attenuates Δ9-THC withdrawal and NSAID-induced gastric inflammation.

Authors:  K R Trexler; M L Eckard; S G Kinsey
Journal:  Pharmacol Biochem Behav       Date:  2018-12-28       Impact factor: 3.533

Review 6.  Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.

Authors:  Rudolf Schicho; Martin Storr
Journal:  Can J Gastroenterol       Date:  2011-07       Impact factor: 3.522

Review 7.  Peripheral signals mediate the beneficial effects of gastric surgery in obesity.

Authors:  Silvia Barja-Fernández; Cintia Folgueira; Cecilia Castelao; Rosaura Leis; Felipe F Casanueva; Luisa M Seoane
Journal:  Gastroenterol Res Pract       Date:  2015-04-15       Impact factor: 2.260

Review 8.  Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint.

Authors:  Aniello Schiano Moriello; Vincenzo Di Marzo; Stefania Petrosino
Journal:  Animals (Basel)       Date:  2022-01-31       Impact factor: 2.752

Review 9.  Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.

Authors:  S Barja-Fernandez; R Leis; F F Casanueva; L M Seoane
Journal:  Drug Des Devel Ther       Date:  2014-12-01       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.